Lotus Bio Technology Development Stock Today
LBTD Stock | USD 0.01 0.00 0.00% |
PerformanceVery Weak
| Odds Of DistressBelow Average
|
Lotus Bio-Technology is trading at 0.01 as of the 26th of March 2025, a No Change since the beginning of the trading day. The stock's lowest day price was 0.01. Lotus Bio-Technology has about a 44 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 26th of December 2024 and ending today, the 26th of March 2025. Click here to learn more.
Lotus Bio-Technology Development Corp., a bio-technology development company, focuses on refining organic materials, and production of natural consumer related products in China. Lotus Bio-Technology Development Corp. was founded in 2011 and is based in Cave Creek, Arizona. The company has 782.77 M outstanding shares. More on Lotus Bio Technology Development
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Lotus Pink Sheet Highlights
President CEO, Director | Zoltan Nagy |
Business Concentration | Consumer Discretionary, Media (discontinued effective close of September 28, 2018), Agricultural Inputs, Basic Materials (View all Sectors) |
Lotus Bio Technology Development [LBTD] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Micro-Cap' category with a current market capitalization of 13.78 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Lotus Bio-Technology's market, we take the total number of its shares issued and multiply it by Lotus Bio-Technology's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Lotus Bio Technology conducts business under Media (discontinued effective close of September 28, 2018) sector and is part of Consumer Discretionary industry. The entity has 782.77 M outstanding shares.
Lotus Bio Technology Development currently holds about 1 in cash with (17.75 K) of positive cash flow from operations.
Check Lotus Bio-Technology Probability Of Bankruptcy
Ownership AllocationLotus Bio Technology maintains a total of 782.77 Million outstanding shares. Lotus Bio Technology Development secures majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 60.4 % of Lotus Bio Technology Development outstanding shares that are owned by insiders conveys that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Lotus Ownership Details
Lotus Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Lotus Bio-Technology without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Financial Widgets Now
Financial WidgetsEasily integrated Macroaxis content with over 30 different plug-and-play financial widgets |
All Next | Launch Module |
Other Information on Investing in Lotus Pink Sheet
Lotus Bio-Technology financial ratios help investors to determine whether Lotus Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Lotus with respect to the benefits of owning Lotus Bio-Technology security.